from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3602c/panC

LFCtreatmentdescriptionclass of inhibitor

0.051

Amikacinug/mL Amikacintranslation

0.419

Cap5-10ug/mL Capreomycintranslation

1.764

Rox10-50 ug/mL Roxithromycintranslation

0.750

SM2-5 ug/mL Streptomycintranslation

0.729

Tet5-10 ug/mL Tetracyclinetranslation

-1.010

Rif0.2-5ug/mL Rifampicintranscription

-0.606

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.411

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.599

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.320

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.671

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.083

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.877

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.005

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.547

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.033

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.156

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.045

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.769

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.916

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.831

KCN5-20 ug/mL Potassium cyaniderespiration

-0.581

NaN30.2-2 mM Sodium aziderespiration

0.190

Nigericin50 uM Nigericinrespiration

-1.117

TRC10-150 ug/mL Triclosanrespiration

0.429

TRZ10-25 ug/mL Thioridazinerespiration

1.530

Valinomycin0.5-10 uM Valinomycinrespiration

-1.126

ZnSO42 mM ZnSO4respiration

-0.181

menadione6-10 ug/mL Menadionerespiration

0.448

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.318

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.012

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.408

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.032

NRP_1Non-replicating persistence stage 1dosRassociated

0.625

Amp0.2mg/mL AmpicillincellWall

0.166

Cephalexin20-100 ug/mL CephalexincellWall

0.647

Cerulenin0.32-5 ug/mL CerulenincellWall

0.079

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.322

EMB10-20 ug/mL EthambutolcellWall

1.242

Eta12-40 ug/mL EthionamidecellWall

1.200

INH0.2-0.4 ug/mL IsoniazidcellWall

1.999

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.193

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.138

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.262

BZA0.12 mg/mL BenzamidearomaticAmides

-0.890

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.598

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.155

H2O24 mM hydrogen peroxideDNAdamaging

-0.063

Levo10 ug/mL LevofloxacinDNAdamaging

0.833

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.517

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.374

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.418

UVUV-irradiationDNAdamaging

-0.628

ARP41-4 ug/mL Antitubercular compound ARP4?

0.530

Antimycin12.5-50 ug/mL Antimycin A?

1.159

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.191

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.267

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.781

PA8240.2-2 ug/mL PA-824?

-0.209

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.153

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.249

Verapamil50 uM Verapamil?

0.268

mercaptoethanol2 mM 2-Mercaptoethanol?

0.818

methoxatin10-20 ug/mL Methoxatin?